GISAMARUK LTD

Company number 14469037 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

GISAMARUK LTD - Analysis Report

Company Number: 14469037

Analysis Date: 2025-07-29 13:54 UTC

Financial Health Assessment: GISAMARUK LTD (as at 31 December 2023)


1. Financial Health Score: D

Explanation:
The company exhibits significant financial strain, evidenced by net liabilities, heavy short-term obligations, and reliance on director/shareholder support. While the company holds valuable investment property assets, its current liabilities far exceed current assets, indicating liquidity distress. Without immediate corrective action, the financial health is precarious.


2. Key Vital Signs

Vital Sign Figure (£) Interpretation
Investment Property (Fixed Asset) 2,936,690 Strong asset base in real estate; a vital long-term asset with potential value stability.
Current Assets 5,500 Very low liquid or near-liquid assets, indicating poor short-term cash availability.
Current Liabilities 1,707,686 Extremely high short-term debts/creditors, creating liquidity pressure (“symptom of distress”).
Net Current Assets -1,702,186 Negative working capital, indicating inability to cover short-term obligations with available assets.
Long-Term Creditors (Bank loans) 1,389,803 Significant long-term debt, creating a financial burden and fixed repayment obligations.
Net (Liabilities)/Assets -155,299 Negative net worth; total liabilities exceed total assets, indicating insolvency on a balance sheet basis.
Share Capital 2,880 Minimal equity injection, insufficient to buffer losses or debts.
Profit & Loss Reserve -158,179 Accumulated losses from operations, indicating unprofitable performance since inception.

3. Diagnosis

Symptoms Analysis:

  • The company possesses a valuable investment property portfolio (£2.94M), which represents its primary asset and potential source of value recovery.
  • However, the liquidity position is critically weak, with current liabilities of £1.7M dwarfing current assets of only £5.5k. This is akin to a patient having a strong heart (asset base) but dangerously low blood pressure (cash/liquidity).
  • Negative working capital (-£1.7M) suggests the company may struggle to meet short-term debts as they fall due, posing a risk of operational disruption or default.
  • The substantial bank loan (£1.39M) falling due in 1-2 years adds pressure, requiring refinancing or repayment capacity.
  • The net liabilities of £155k reflect accumulated losses and overall financial distress, signaling the company is technically insolvent on a balance sheet basis at this stage.
  • Directors acknowledge reliance on shareholder/directed financial support to continue operations, indicating the company is “critically ill” but currently sustained by external aid.
  • No audit requirement due to micro/small company status; accounts unaudited which limits external verification of financial robustness.
  • The company is newly incorporated (Nov 2022) and this is the first financial year, so the negative equity might partly reflect start-up costs and initial capital structure. Still, the scale of short-term liabilities is concerning.

4. Recommendations

Immediate Actions to Improve Financial Wellness:

  1. Improve Liquidity:

    • Convert part of investment property or secure additional short-term financing to boost cash reserves and meet current liabilities.
    • Consider renegotiating payment terms with creditors to alleviate immediate cash flow strain.
  2. Debt Restructuring:

    • Engage with bank/lenders to explore restructuring long-term debt to manageable repayment schedules or refinancing options.
    • Explore equity injection from existing or new shareholders to strengthen capital base and reduce reliance on debt.
  3. Operational Efficiency:

    • Review and control operating expenses given the negative profit and loss reserve to halt further losses.
    • Establish detailed cash flow forecasting and monitoring to anticipate liquidity gaps early.
  4. Strategic Asset Management:

    • Evaluate investment property portfolio for potential sale or leveraging to generate working capital.
    • Regularly revalue properties to reflect true market conditions and adjust strategy accordingly.
  5. Governance and Reporting:

    • Although audit exemption applies, consider voluntary audit or independent financial review to bolster credibility with stakeholders.
    • Strengthen financial controls and reporting to provide early warning of financial distress symptoms.

Summary

GISAMARUK LTD shows a significant asset base in investment property but faces acute liquidity challenges due to excessive current liabilities and negative working capital. The company is currently dependent on director/shareholder support to continue operating, reflecting financial fragility. Immediate focus on improving cash flow, restructuring debt, and possibly raising equity is essential to restore financial health and avoid insolvency risk.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.